EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: another piece to the puzzle.
作者信息
Fornaro L, Crea F, Masi G, Paolicchi E, Loupakis F, Graziano F, Salvatore L, Ronzoni M, Ricci V, Cremolini C, Schirripa M, Danesi R, Falcone A
机构信息
Department of Oncology, Transplants and New Technologies in Medicine, Division of Medical Oncology, University of Pisa, Pisa.
Department of Internal Medicine, Division of Pharmacology, University of Pisa, Pisa.
出版信息
Ann Oncol. 2012 May;23(5):1370-1371. doi: 10.1093/annonc/mds031. Epub 2012 Mar 1.
PMID:22383679
Abstract
摘要
Zotero 插件